Artms Incis A Biotechnology Company Based In Vancouverspecializing In Advanced Cyclotron Based Isotope Production Technologies For Medical Applicationsoriginally A Spin Off From Triumfcanadaae S Particle Accelerator Centerartms Was Acquired By Telix Pharmaceuticals In April 2024Which Enhances Its Global Reach In The Field Of Radiopharmaceuticalsthe Company Focuses On Decentralizing Isotope Production To Improve Patient Access To Essential Diagnostic And Therapeutic Radiopharmaceuticals The Core Product Offerings Include The Quantm Irradiation Systemqisa C Which Enables High Efficiencylarge Scale Manufacturing Of Isotopes Like Zirconium 89 And Gallium 68Artms Also Provides Quantm Targetsconsumable Targets That Work With Qisa C To Produce Isotopes On Demandand Maintains Ultra Pure Rare Metals Necessary For Target Productiontheir Innovative Platform Allows Local Medical Cyclotrons To Produce Isotopes At Scaleaddressing Shortages And Supporting Timely Patient Care In Cancer Imaging And Therapy
